Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 6, 2019
The oncological safety of hysteroscopy in the diagnosis of early-stage endometrial cancer: An Israel gynecologic oncology group studyAhmet Namazov, Ofer Gemer, Limor Helpman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 19, 2020
Increased ultrasonographic endometrial thickness is associated with poor survival in patients with endometrial cancer: An Israel gynecologic oncology group studyAhmet Namazov, Ofer Gemer, Nasreen Hag-Yahia, et al.
Acta Obstetricia Et Gynecologica Scandinavica|October 22, 2020
Age is an independent predictor of outcome in endometrial cancer patients: An Israeli Gynecology Oncology Group cohort studyNasreen Hag-Yahia, Ofer Gemer, Ram Eitan, et al.
American Journal of Clinical Oncology|March 4, 2015
Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical CancerOfer Gemer, Ofer Lavie, Michael Gdalevich, et al.
American Journal of Obstetrics and Gynecology|May 25, 2018
Is there a survival advantage in diagnosing endometrial cancer in asymptomatic postmenopausal patients? An Israeli Gynecology Oncology Group studyOfer Gemer, Yakir Segev, Limor Helpman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 5, 2014
Integration of PET/CT into the preoperative evaluation of patients with early cervical cancer does not decrease the proportion of patients with positive lymph nodes found after surgeryOfer Gemer, Ram Eitan, Michael Gdalevich, et al.
Gynecologic Oncology|May 30, 2018
Postoperative radiation rates in stage IIA1 cervical cancer: Is surgical treatment justified? An Israeli Gynecologic Oncology Group StudyYael Yagur, Omer Weitzner, Ofer Gemer, et al.
The Oncologist|September 19, 2025
Phase 3 clinical trials evaluating poly(ADP-ribose) polymerase inhibition plus immunotherapy for first-line treatment of advanced ovarian cancerB J Rimel, Eric Pujade-Lauraine, Kathleen Moore, et al.
Molecular & Cellular Proteomics : MCP|February 15, 2019
Microvesicle Proteomic Profiling of Uterine Liquid Biopsy for Ovarian Cancer Early DetectionGeorgina D Barnabas, Keren Bahar-Shany, Stav Sapoznik, et al.
Cancer Immunology Research|May 16, 2024
PVRIG is Expressed on Stem-Like T Cells in Dendritic Cell-Rich Niches in Tumors and Its Blockade May Induce Immune Infiltration in Non-Inflamed TumorsZoya Alteber, Gady Cojocaru, Roy Z Granit, et al.
Pageof 8